Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Prostate Cancer

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    April 2010
  1. LIU T , Wu LY, Choi JK, Berkman CE, et al
    Targeted photodynamic therapy for prostate cancer: Inducing apoptosis via activation of the caspase-8/-3 cascade pathway.
    Int J Oncol. 2010;36:777-84.
    PubMed     Text format     Related articles    Abstract available


    March 2010
  2. LIU Y , Wu X, Dong Z, Lu S, et al
    The molecular mechanism of Vav3 oncogene on upregulation of androgen receptor activity in prostate cancer cells.
    Int J Oncol. 2010;36:623-33.
    PubMed     Text format     Related articles    Abstract available


    February 2010
  3. LU S , Tan Z, Wortman M, Lu S, et al
    Regulation of heat shock protein 70-1 expression by androgen receptor and its signaling in human prostate cancer cells.
    Int J Oncol. 2010;36:459-67.
    PubMed     Text format     Related articles    Abstract available


  4. BAI VU , Murthy S, Chinnakannu K, Muhletaler F, et al
    Androgen regulated TRPM8 expression: a potential mRNA marker for metastatic prostate cancer detection in body fluids.
    Int J Oncol. 2010;36:443-50.
    PubMed     Text format     Related articles    Abstract available


    January 2010
  5. YANG J , Wu Z, Wu D, Darby MV, et al
    Pharmacokinetics, biodistribution and metabolism of a novel selective androgen receptor modulator designed for prostate cancer imaging.
    Int J Oncol. 2010;36:213-22.
    PubMed     Text format     Related articles    Abstract available


  6. YOON SJ , Park SY, Pang PC, Gallagher J, et al
    N-glycosylation status of beta-haptoglobin in sera of patients with prostate cancer vs. benign prostate diseases.
    Int J Oncol. 2010;36:193-203.
    PubMed     Text format     Related articles    Abstract available


  7. FOROOTAN SS , Bao ZZ, Forootan FS, Kamalian L, et al
    Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenografts.
    Int J Oncol. 2010;36:69-76.
    PubMed     Text format     Related articles    Abstract available


    December 2009
  8. ZHANG N , Sanders AJ, Ye L, Kynaston HG, et al
    Vascular endothelial growth inhibitor, expression in human prostate cancer tissue and the impact on adhesion and migration of prostate cancer cells in vitro.
    Int J Oncol. 2009;35:1473-80.
    PubMed     Text format     Related articles    Abstract available


  9. CANG S , Feng J, Konno S, Han L, et al
    Deficient histone acetylation and excessive deacetylase activity as epigenomic marks of prostate cancer cells.
    Int J Oncol. 2009;35:1417-22.
    PubMed     Text format     Related articles    Abstract available


    November 2009
  10. KAJANNE R , Miettinen P, Tenhunen M, Leppa S, et al
    Transcription factor AP-1 promotes growth and radioresistance in prostate cancer cells.
    Int J Oncol. 2009;35:1175-82.
    PubMed     Text format     Related articles    Abstract available


  11. GRAVINA GL , Biordi L, Martella F, Flati V, et al
    Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancer.
    Int J Oncol. 2009;35:1133-9.
    PubMed     Text format     Related articles    Abstract available


    October 2009
  12. TIMOFEEVA OA , Zhang X, Ressom HW, Varghese RS, et al
    Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men.
    Int J Oncol. 2009;35:751-60.
    PubMed     Text format     Related articles    Abstract available


  13. VAN SLAMBROUCK S , Hilkens J, Bisoffi M, Steelant WF, et al
    AsialoGM1 and integrin alpha2beta1 mediate prostate cancer progression.
    Int J Oncol. 2009;35:693-9.
    PubMed     Text format     Related articles    Abstract available


    September 2009
  14. ENDO T , Uzawa K, Suzuki H, Tanzawa H, et al
    Characteristic gene expression profiles of benign prostatic hypertrophy and prostate cancer.
    Int J Oncol. 2009;35:499-509.
    PubMed     Text format     Related articles    Abstract available


  15. BOYIRI T , Somiari RI, Russell S, Aliaga C, et al
    Proteomics of rat prostate lobes treated with 2-N-hydroxylamino-1-methyl-6-phenylimidazo[4,5-b]pyridine, 5alpha-dihydrotestosterone, individually and in combination.
    Int J Oncol. 2009;35:559-67.
    PubMed     Text format     Related articles    Abstract available


  16. HAALAND CM , Heaphy CM, Butler KS, Fischer EG, et al
    Differential gene expression in tumor adjacent histologically normal prostatic tissue indicates field cancerization.
    Int J Oncol. 2009;35:537-46.
    PubMed     Text format     Related articles    Abstract available


    August 2009
  17. BELPOMME D , Irigaray P, Landau-Ossondo M, Martin M, et al
    Addendum: The growing incidence of prostate cancer in the French Caribbean islands, Martinique and Guadeloupe: A possible causal role of pesticides.
    Int J Oncol. 2009;35:433.
    PubMed     Text format     Related articles   


    July 2009
  18. PARADOWSKA A , Fenic I, Konrad L, Sturm K, et al
    Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
    Int J Oncol. 2009;35:87-96.
    PubMed     Text format     Related articles    Abstract available


    June 2009
  19. VAN SLAMBROUCK S , Jenkins AR, Romero AE, Steelant WF, et al
    Reorganization of the integrin alpha2 subunit controls cell adhesion and cancer cell invasion in prostate cancer.
    Int J Oncol. 2009;34:1717-26.
    PubMed     Text format     Related articles    Abstract available


  20. SHUKLA S , Shukla M, Maclennan GT, Fu P, et al
    Deregulation of FOXO3A during prostate cancer progression.
    Int J Oncol. 2009;34:1613-20.
    PubMed     Text format     Related articles    Abstract available


  21. MORI K , Enokida H, Kagara I, Kawakami K, et al
    CpG hypermethylation of collagen type I alpha 2 contributes to proliferation and migration activity of human bladder cancer.
    Int J Oncol. 2009;34:1593-602.
    PubMed     Text format     Related articles    Abstract available


    May 2009
  22. DE GANCK A , De Corte V, Bruyneel E, Bracke M, et al
    Down-regulation of myopodin expression reduces invasion and motility of PC-3 prostate cancer cells.
    Int J Oncol. 2009;34:1403-9.
    PubMed     Text format     Related articles    Abstract available


  23. GNANASEKAR M , Thirugnanam S, Zheng G, Chen A, et al
    Gene silencing of translationally controlled tumor protein (TCTP) by siRNA inhibits cell growth and induces apoptosis of human prostate cancer cells.
    Int J Oncol. 2009;34:1241-6.
    PubMed     Text format     Related articles    Abstract available


  24. CHOI MS , Oh JH, Kim SM, Jung HY, et al
    Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells.
    Int J Oncol. 2009;34:1221-30.
    PubMed     Text format     Related articles    Abstract available


  25. HERMAN JG , Stadelman HL, Roselli CE
    Curcumin blocks CCL2-induced adhesion, motility and invasion, in part, through down-regulation of CCL2 expression and proteolytic activity.
    Int J Oncol. 2009;34:1319-27.
    PubMed     Text format     Related articles    Abstract available


    April 2009
  26. BELPOMME D , Irigaray P, Ossondo M, Vacque D, et al
    Prostate cancer as an environmental disease: An ecological study in the French Caribbean islands, Martinique and Guadeloupe.
    Int J Oncol. 2009;34:1037-44.
    PubMed     Text format     Related articles    Abstract available


    March 2009
  27. WEAVER J , Briscoe T, Hou M, Goodman C, et al
    Strawberry polyphenols are equally cytotoxic to tumourigenic and normal human breast and prostate cell lines.
    Int J Oncol. 2009;34:777-86.
    PubMed     Text format     Related articles    Abstract available


  28. WATANABE M , Kashiwakura Y, Huang P, Ochiai K, et al
    Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression.
    Int J Oncol. 2009;34:657-63.
    PubMed     Text format     Related articles    Abstract available


    February 2009
  29. MOHAMED ER , Naito M, Terasaki Y, Niu Y, et al
    Capability of SART3109-118 peptide to induce cytotoxic T lymphocytes from prostate cancer patients with HLA class I-A11, -A31 and -A33 alleles.
    Int J Oncol. 2009;34:529-36.
    PubMed     Text format     Related articles    Abstract available


  30. ARENCIBIA JM , Martin S, Perez-Rodriguez FJ, Bonnin A, et al
    Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.
    Int J Oncol. 2009;34:457-63.
    PubMed     Text format     Related articles    Abstract available


  31. GNANASEKAR M , Thirugnanam S, Ramaswamy K
    Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMGB1) expression leads to inhibition of prostate cancer cell survival and apoptosis.
    Int J Oncol. 2009;34:425-31.
    PubMed     Text format     Related articles    Abstract available


    September 2008
  32. MUKHERJEE B , Mayer D
    Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
    Int J Oncol. 2008;33:623-9.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: